163 related articles for article (PubMed ID: 6176107)
1. Renal response to angiotensin-converting enzyme inhibition.
Hollenberg NK
Am J Cardiol; 1982 Apr; 49(6):1425-9. PubMed ID: 6176107
[TBL] [Abstract][Full Text] [Related]
2. Converting enzyme inhibition: implications for renal perfusion and function.
Hollenberg NK
Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
[TBL] [Abstract][Full Text] [Related]
3. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
Stumpe KO
Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
[TBL] [Abstract][Full Text] [Related]
4. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
Hollenberg NK
Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
6. Converting enzyme inhibition and the kidney.
Meggs LG; Hollenberg NK
Hypertension; 1980; 2(4):551-7. PubMed ID: 6156899
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Cohn JN; Levine TB
Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
[TBL] [Abstract][Full Text] [Related]
8. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
9. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Bauer JH; Reams GP
Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Dzau VJ
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
[TBL] [Abstract][Full Text] [Related]
12. Drug suppression of the angiotensin system in congestive heart failure.
Sullivan JM
Annu Rev Med; 1983; 34():169-77. PubMed ID: 6190432
[TBL] [Abstract][Full Text] [Related]
13. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Cody RJ; Laragh JH; Atlas SA; Case DB
J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
[TBL] [Abstract][Full Text] [Related]
14. Specificity of renal vasodilation with captopril: saralasin prevents the response in the DOCA-treated, salt-loaded rabbit.
Hollenberg NK; Passan DR
Life Sci; 1982 Jul; 31(4):329-34. PubMed ID: 6755124
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Cody RJ
Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
Kramer HJ
Z Kardiol; 1988; 77 Suppl 3():39-45. PubMed ID: 3062959
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
Bauer JH
Am J Med; 1984 Aug; 77(2A):43-51. PubMed ID: 6206722
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
Heller J; Kramer HJ; Horácek V
Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure.
Gavras H; Brunner HR
Hypertension; 2001 Feb; 37(2 Pt 2):342-5. PubMed ID: 11230297
[TBL] [Abstract][Full Text] [Related]
20. Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
Robertson JI
J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S2-8. PubMed ID: 2422488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
